Moderna (NasdaqGS:MRNA) plans to present Phase 1/2 data for its mRNA-4359 cancer antigen therapy combined with pembrolizumab ...

With the introduction of mRNA vaccines in the 2010s – vaccines that use messenger RNA molecules in cells to train the body to ...

Moderna moved its H5N1 vaccine candidate into the first late-stage human trial for a pandemic bird flu shot made with mRNA ...

An mRNA vaccine for avian influenza, developed by pharma company Moderna, has begun Phase 3 human trials. Building on the ...

A program that got caught up in HHS’ decision to abandon mRNA research was revived by a public-private coalition and is now ...

Indian American physician-scientist Dr. Vinod Balachandran says mRNA vaccines may reduce risk of disease coming back after ...

The treatment staved off cancer for seven of eight patients with a condition where the odds are rarely that good.

Phase 3 study is supported by the Coalition for Epidemic Preparedness Innovations to help strengthen global preparedness against a significant pandemic threat. CAMBRIDGE, MA / ACC ...

The Department of Health and Human Services had canceled hundreds of millions of dollars in funding previously committed help ...

Dr. Elias Sayour says the mRNA vaccine is helping shed new light on cancer treatments. “There have been patients that have ...

EDITOR’S NOTE: The views expressed in this commentary are solely those of the writer. CNN is showcasing the work of The Conversation, a collaboration between journalists and academics to provide news ...

German biotech firm CureVac has filed a lawsuit against Moderna in Delaware, alleging patent infringement of its mRNA technology in Moderna's COVID-19 vaccine, Spikevax. The case is among several ...